Paris, France

Christian Lerche

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2016.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christian Lerche - Innovator in Dual Drug Delivery Systems

Introduction

Christian Lerche is a notable inventor based in Paris, France. He has made significant contributions to the field of medical devices, particularly in the development of injection systems. His innovative approach focuses on enhancing the delivery of multiple medicaments through a single device.

Latest Patents

Christian Lerche holds a patent for a dual drug pen-injection device with micro-reservoirs. This device is designed to deliver at least two medicaments, where the first medicament is administered in settable doses through a dedicated delivery mechanism. The second medicament is stored in micro-reservoirs and is activated upon the use of a secondary delivery system. Notably, the activation of this second system locks out the first medicament delivery mechanism, ensuring precise control over the administration of the drugs. He has 1 patent to his name.

Career Highlights

Christian Lerche is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other talented professionals in the field, contributing to advancements in medical technology.

Collaborations

One of his notable coworkers is Amit Kohli, with whom he has likely shared insights and expertise in the development of innovative medical solutions.

Conclusion

Christian Lerche's contributions to the field of dual drug delivery systems exemplify his commitment to improving patient care through innovation. His work continues to influence the medical device industry, paving the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…